Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.

Bellur SS, Lepeytre F, Vorobyeva O, Troyanov S, Cook HT, Roberts IS; International IgA Nephropathy Working Group.

Kidney Int. 2017 Jan;91(1):235-243. doi: 10.1016/j.kint.2016.09.029. Epub 2016 Dec 1.

2.

Bullous Pemphigoid With a Dual Pattern of Glomerular Immune Complex Disease.

Hoorn EJ, Taams NE, Hurskainen T, Salih M, Weening JJ, Jonkman MF, Pas HH, Schreurs MW.

Am J Kidney Dis. 2016 Feb;67(2):302-6. doi: 10.1053/j.ajkd.2015.10.015. Epub 2015 Nov 24.

PMID:
26616334
3.

Advances in the pathology of glomerular diseases.

Weening JJ, Ronco P, Remuzzi G.

Contrib Nephrol. 2013;181:12-21. doi: 10.1159/000348639. Epub 2013 May 8. Review.

4.

Acute kidney injury during therapy with an antisense oligonucleotide directed against PCSK9.

van Poelgeest EP, Swart RM, Betjes MG, Moerland M, Weening JJ, Tessier Y, Hodges MR, Levin AA, Burggraaf J.

Am J Kidney Dis. 2013 Oct;62(4):796-800. doi: 10.1053/j.ajkd.2013.02.359. Epub 2013 Apr 3.

PMID:
23561896
5.

Kidney disease in lupus is not always 'lupus nephritis'.

Anders HJ, Weening JJ.

Arthritis Res Ther. 2013 Mar 1;15(2):108. doi: 10.1186/ar4166.

6.

A position paper on standardizing the nonneoplastic kidney biopsy report.

Chang A, Gibson IW, Cohen AH, Weening JJ, Jennette JC, Fogo AB; Renal Pathology Society.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1365-8. Epub 2012 Jul 12.

7.

Historical milestones in renal pathology.

Weening JJ, Jennette JC.

Virchows Arch. 2012 Jul;461(1):3-11. doi: 10.1007/s00428-012-1254-7. Epub 2012 Jun 3. No abstract available.

8.

Will laboratory markers replace kidney biopsy in patients with nephrotic syndrome?

Weening JJ.

Neth J Med. 2012 Apr;70(3):107-8. No abstract available.

9.

Ruptured pseudoaneurysm in a renal allograft after percutaneous biopsy.

Klop KW, Karatepe O, Weening JJ, van Agteren M, Dor FJ.

Kidney Int. 2012 Feb;81(4):420. doi: 10.1038/ki.2011.361. No abstract available.

10.

Stem cell factor expression after renal ischemia promotes tubular epithelial survival.

Stokman G, Stroo I, Claessen N, Teske GJ, Weening JJ, Leemans JC, Florquin S.

PLoS One. 2010 Dec 21;5(12):e14386. doi: 10.1371/journal.pone.0014386.

11.

Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis.

Ito Y, Aten J, Nguyen TQ, Joles JA, Matsuo S, Weening JJ, Goldschmeding R.

Nephron Exp Nephrol. 2011;117(1):e9-20. doi: 10.1159/000319652. Epub 2010 Aug 4.

PMID:
20689330
12.

Expression patterns of connective tissue growth factor and of TGF-beta isoforms during glomerular injury recapitulate glomerulogenesis.

Ito Y, Goldschmeding R, Kasuga H, Claessen N, Nakayama M, Yuzawa Y, Sawai A, Matsuo S, Weening JJ, Aten J.

Am J Physiol Renal Physiol. 2010 Sep;299(3):F545-58. doi: 10.1152/ajprenal.00120.2009. Epub 2010 Jun 24.

13.

Exciting times for renal medicine.

Weening JJ, Remuzzi G.

Lancet. 2010 Apr 10;375(9722):1227-8. doi: 10.1016/S0140-6736(10)60283-8. No abstract available.

PMID:
20382312
14.

The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults.

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator SN, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo AB, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

Kidney Int. 2010 May;77(10):921-7. doi: 10.1038/ki.2010.43. Epub 2010 Mar 3.

15.

Subpubic cartilaginous cystic lesion presenting as a vulvar mass: a case report.

Hoogendoorn R, Kayser H, Weening J, van Geloven A.

J Med Case Rep. 2009 May 29;3:7294. doi: 10.1186/1752-1947-3-7294.

16.

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

Kidney Int. 2009 Sep;76(5):534-45. doi: 10.1038/ki.2009.243. Epub 2009 Jul 1.

17.

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

Kidney Int. 2009 Sep;76(5):546-56. doi: 10.1038/ki.2009.168. Epub 2009 Jul 1.

18.

Quiz page. Muckle Wells syndrome.

Roodnat JI, de Theije-Kors E, Weening JJ, Weimar W, van Daele PL.

Am J Kidney Dis. 2008 Nov;52(5):A47-9. doi: 10.1053/j.ajkd.2008.07.005. No abstract available.

PMID:
18971008
19.

Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection.

Roelofs JJ, Rouschop KM, Teske GJ, Wagenaar GT, Claessen N, Weening JJ, van der Poll T, Florquin S.

Nephrol Dial Transplant. 2009 Mar;24(3):801-8. doi: 10.1093/ndt/gfn562. Epub 2008 Oct 8.

PMID:
18842674
20.

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.

Deegens JK, Dijkman HB, Borm GF, Steenbergen EJ, van den Berg JG, Weening JJ, Wetzels JF.

Kidney Int. 2008 Dec;74(12):1568-76. doi: 10.1038/ki.2008.413. Epub 2008 Aug 27.

21.

Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis.

Roelofs JJ, Teske GJ, Bonta PI, de Vries CJ, Meijers JC, Weening JJ, van der Poll T, Florquin S.

Kidney Int. 2009 Jan;75(1):52-9. doi: 10.1038/ki.2008.454. Epub 2008 Sep 17.

22.

The art of classifying renal allograft pathology.

Weening JJ.

Nat Clin Pract Nephrol. 2008 Aug;4(8):420-1. doi: 10.1038/ncpneph0859. Epub 2008 Jul 1. No abstract available.

PMID:
18594502
23.

Enhanced mobilization of bone marrow cells does not ameliorate renal fibrosis.

Stokman G, Leemans JC, Stroo I, Hoedemaeker I, Claessen N, Teske GJ, Weening JJ, Florquin S.

Nephrol Dial Transplant. 2008 Feb;23(2):483-91. Epub 2007 Nov 7.

PMID:
17989101
24.

Ibuprofen-induced HUS.

Schoenmaker NJ, Weening JJ, Krediet RT.

Clin Nephrol. 2007 Sep;68(3):177-8.

PMID:
17915621
25.

A case of acute renal failure.

Adler SG, Weening JJ.

Clin J Am Soc Nephrol. 2006 Jan;1(1):158-65. Epub 2005 Oct 26. No abstract available.

26.

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').

Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ.

Am J Transplant. 2007 Mar;7(3):518-26.

27.

Peri-implant tissue is an important niche for Staphylococcus epidermidis in experimental biomaterial-associated infection in mice.

Broekhuizen CA, de Boer L, Schipper K, Jones CD, Quadir S, Feldman RG, Dankert J, Vandenbroucke-Grauls CM, Weening JJ, Zaat SA.

Infect Immun. 2007 Mar;75(3):1129-36. Epub 2006 Dec 11.

28.

Urothelial CD44 facilitates Escherichia coli infection of the murine urinary tract.

Rouschop KM, Sylva M, Teske GJ, Hoedemaeker I, Pals ST, Weening JJ, van der Poll T, Florquin S.

J Immunol. 2006 Nov 15;177(10):7225-32.

29.

The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritis.

Roelofs JJ, Rouschop KM, Teske GJ, Claessen N, Weening JJ, van der Poll T, Florquin S.

Kidney Int. 2006 Dec;70(11):1942-7. Epub 2006 Oct 11.

30.

Kidney failure in mice lacking the tetraspanin CD151.

Sachs N, Kreft M, van den Bergh Weerman MA, Beynon AJ, Peters TA, Weening JJ, Sonnenberg A.

J Cell Biol. 2006 Oct 9;175(1):33-9. Epub 2006 Oct 2.

31.

Renal expression of CD44 correlates with acute renal allograft rejection.

Rouschop KM, Roelofs JJ, Sylva M, Rowshani AT, Ten Berge IJ, Weening JJ, Florquin S.

Kidney Int. 2006 Sep;70(6):1127-34. Epub 2006 Jul 26.

32.

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.

Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

Kidney Int. 2006 Aug;70(4):732-42. Epub 2006 Jul 5.

33.

Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells.

Dijkman HB, Weening JJ, Smeets B, Verrijp KC, van Kuppevelt TH, Assmann KK, Steenbergen EJ, Wetzels JF.

Kidney Int. 2006 Jul;70(2):338-44. Epub 2006 Jun 7.

34.

CCL18: a urinary marker of Gaucher cell burden in Gaucher patients.

Boot RG, Verhoek M, Langeveld M, Renkema GH, Hollak CE, Weening JJ, Donker-Koopman WE, Groener JE, Aerts JM.

J Inherit Metab Dis. 2006 Aug;29(4):564-71. Epub 2006 May 30.

PMID:
16736095
35.

CD44 disruption prevents degeneration of the capillary network in obstructive nephropathy via reduction of TGF-beta1-induced apoptosis.

Rouschop KM, Claessen N, Pals ST, Weening JJ, Florquin S.

J Am Soc Nephrol. 2006 Mar;17(3):746-53. Epub 2006 Feb 1.

36.

Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatment.

Davin JC, Olie KH, Verlaak R, Horuz F, Florquin S, Weening JJ, Groothoff JW, Strain L, Goodship TH.

Am J Kidney Dis. 2006 Feb;47(2):e27-30.

PMID:
16431247
37.

Nephrologists sans frontières.

Weening JJ.

Kidney Int. 2006 Jan;69(1):5-6. No abstract available.

38.

Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury.

Roelofs JJ, Rouschop KM, Leemans JC, Claessen N, de Boer AM, Frederiks WM, Lijnen HR, Weening JJ, Florquin S.

J Am Soc Nephrol. 2006 Jan;17(1):131-40. Epub 2005 Nov 16.

39.

Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney.

Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S.

J Clin Invest. 2005 Oct;115(10):2894-903.

40.

Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection.

Rouschop KM, Roelofs JJ, Rowshani AT, Leemans JC, van der Poll T, Ten Berge IJ, Weening JJ, Florquin S.

Nephrol Dial Transplant. 2005 Oct;20(10):2248-54.

PMID:
16166750
41.

Massive oedema in a Cape Verde sailor.

de Graaff AE, Weening JJ, Krediet RT.

Nephrol Dial Transplant. 2005 Nov;20(11):2545-7. Epub 2005 Sep 2. No abstract available.

PMID:
16141460
42.

Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration.

Dirks JH, de Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, Bennett PH, El Nahas M, Valdes RH, Kaseje D, Katz IJ, Naicker S, Rodriguez-Iturbe B, Schieppati A, Shaheen F, Sitthi-Amorn C, Solez K, Viberti G, Remuzzi G, Weening JJ; International Society of Nephrology Commission for the Global Advancement of Nephrology Study Group 2004.

Kidney Int Suppl. 2005 Sep;(98):S1-6.

43.

Protection against renal ischemia reperfusion injury by CD44 disruption.

Rouschop KM, Roelofs JJ, Claessen N, da Costa Martins P, Zwaginga JJ, Pals ST, Weening JJ, Florquin S.

J Am Soc Nephrol. 2005 Jul;16(7):2034-43. Epub 2005 May 18.

44.

Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution.

Stokman G, Leemans JC, Claessen N, Weening JJ, Florquin S.

J Am Soc Nephrol. 2005 Jun;16(6):1684-92. Epub 2005 Apr 20.

45.

A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004.

Li PK, Weening JJ, Dirks J, Lui SL, Szeto CC, Tang S, Atkins RC, Mitch WE, Chow KM, D'Amico G, Freedman BI, Harris DC, Hooi LS, Jong PE, Kincaid-Smith P, Lai KN, Lee E, Li FK, Lin SY, Lo WK, Mani MK, Mathew T, Murakami M, Qian JQ, Ramirez S, Reiser T, Tomino Y, Tong MK, Tsang WK, Tungsanga K, Wang H, Wong AK, Wong KM, Yang WC, de Zeeuw D, Yu AW, Remuzzi G; Participants of ISN Consensus Workshop on Prevention of Progression of Renal Disease.

Kidney Int Suppl. 2005 Apr;(94):S2-7. Review.

PMID:
15752234
46.

A time to act for prevention.

Li PK, Dirks J, Weening JJ.

Kidney Int Suppl. 2005 Apr;(94):S1. No abstract available.

PMID:
15752223
47.

Albuminuria as early test for vascular disease.

Remuzzi G, Weening JJ.

Lancet. 2005 Feb 12-18;365(9459):556-7. No abstract available.

PMID:
15708086
48.

Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchanges and ganciclovir.

Olie KH, Goodship TH, Verlaak R, Florquin S, Groothoff JW, Strain L, Weening JJ, Davin JC.

Am J Kidney Dis. 2005 Jan;45(1):e12-5.

PMID:
15696434
49.

Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.

van den Berg JG, van den Bergh Weerman MA, Assmann KJ, Weening JJ, Florquin S.

Kidney Int. 2004 Nov;66(5):1901-6.

50.

Advancing nephrology around the globe: an invitation to contribute.

Weening JJ.

J Am Soc Nephrol. 2004 Oct;15(10):2761-2. No abstract available.

Supplemental Content

Loading ...
Support Center